Literature DB >> 27040290

Pharmacologic Treatment for Temporomandibular Disorders.

Harry Dym1, Dustin Bowler2, Joseph Zeidan2.   

Abstract

Pharmacologic agents play an integral role in the overall management of temporomandibular joint disorder. The general dentist should be familiar with the different classes of drugs currently in use for dealing with this often complex medical/dental problem. Published by Elsevier Inc.

Entities:  

Keywords:  Pain; Pharmacologic treatment; Temporomandibular disorders

Mesh：

Substances：

Year:  2016        PMID： 27040290     DOI： 10.1016/j.cden.2015.11.012

Source DB:  PubMed          Journal:  Dent Clin North Am        ISSN： 0011-8532


  4 in total

Review 1.  Recent Tissue Engineering Advances for the Treatment of Temporomandibular Joint Disorders.

Authors:  Ashkan Aryaei; Natalia Vapniarsky; Jerry C Hu; Kyriacos A Athanasiou
Journal:  Curr Osteoporos Rep       Date:  2016-12       Impact factor: 5.096

2.  Research progress on tissue engineering in repairing tempomandibular joint.

Authors:  Chenyu Wang; Yingnan Wang; Cunyi Wang; Jiejun Shi; Huiming Wang
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-04-25

Review 3.  Temporomandibular Joint Regenerative Medicine.

Authors:  Xavier Van Bellinghen; Ysia Idoux-Gillet; Marion Pugliano; Marion Strub; Fabien Bornert; Francois Clauss; Pascale Schwinté; Laetitia Keller; Nadia Benkirane-Jessel; Sabine Kuchler-Bopp; Jean Christophe Lutz; Florence Fioretti
Journal:  Int J Mol Sci       Date:  2018-02-02       Impact factor: 5.923

4.  Efficacy and Safety of Botulinum Toxin Type A on Persistent Myofascial Pain: A Randomized Clinical Trial.

Authors:  Giancarlo De la Torre Canales; Natalia Alvarez-Pinzon; Victor Ricardo Manuel Muñoz-Lora; Leonardo Vieira Peroni; Amanda Farias Gomes; Alfonso Sánchez-Ayala; Francisco Haiter-Neto; Daniele Manfredini; Célia Marisa Rizzatti-Barbosa
Journal:  Toxins (Basel)       Date:  2020-06-15       Impact factor: 4.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.